-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN IE00BYZ5XL97
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
178.227.984 oder 158.000.000
Strongbridge Biopharma PLC underperformed den DAX um -137 % vom 15.10.2015 bis 20.08.2021
Portrait der Aktie: Strongbridge Biopharma PLC
Das Unternehmen Strongbridge Biopharma plc aus Irland beschäftigt 72 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die Strongbridge Biopharma PLC Aktie konnte seit dem 15.10.2015 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -81%.
Dir gefallen die Informationen zu Strongbridge Biopharma PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Strongbridge Biopharma PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Strongbridge Biopharma PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Strongbridge Biopharma PLC?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
43 News & Informationen zur Strongbridge Biopharma PLC Aktie
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
Certain Litigation Relating to the Transaction
As previously disclosed, on May 24, 2021, Strongbridge Biopharma plc entered into a Transaction Agreement with Xeris… | August 30, 2021
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 30, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 27, 2021 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 26, 2021 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 25, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 24, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH…
Xeris Pharmaceuticals Strengthens Its Patent Estate
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
INVESTIGATION: Halper Sadeh LLP Investigates SBBP, QTS, GRA, SWN, ONEM, IKNX; Shareholders are Encouraged to Contact the Firm
NEW YORK, Aug. 16, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
… | August 16, 2021
Xeris Pharmaceuticals Achieves Unprecedented Levels Of Payor Coverage For Gvoke®
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize
Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……
(RTTNews) – Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL…… The following are some of the stocks making big moves in Thursday's pre-market trad…
Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……
The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.26 A.M. EDT)..
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 05, 2021 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER…
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., Aug. 03, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
Xeris Pharmaceuticals : Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
Xeris Pharmaceuticals, Inc. today announced in accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013 that, as of the close of business on July 28, 2021, Xeris'… | July 29, 2021
Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue | Nachricht | finanzen.net
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 27, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 26, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 23, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 22, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 21, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 20, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
AxoGen : Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors (Form 8-K)
Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors
ALACHUA and TAMPA, FL – July 19, 2021 – Axogen, Inc. , a global leader in developing… | July 19, 2021
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 08, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
NEW YORK, July 7, 2021 /PRNewswire/ —
If you own shares in any of the companies… | July 7, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
NEW YORK, July 7, 2021 /PRNewswire/ —
If you own shares in any of the companies listed above and would like to discuss our investigations or have
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 06, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm
NEW YORK, July 3, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
… | July 4, 2021
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., July 02, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…
SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations
NEW YORK, June 29, 2021 /PRNewswire/ –If you own shares in any of the companies listed above and would like to discuss our investigations or have…
Marker Therapeutics, Inc. (MRKR): Are Hedge Funds Right About This Stock?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers…
Form 8.3 – The Vanguard Group, Inc. : Strongbridge Biopharma plc
The Vanguard Group, Inc.
Form 8.3 – The Vanguard Group, Inc.: Strongbridge Biopharma plc
25-Jun-2021 / 14:19 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The… | June 25, 2021
Man Group PLC : Form 8.3 – Strongbridge Biopharma plc
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH…
Best Penny Stocks to Buy Right Now? 15 To Watch In July
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., June 24, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,…
INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
NEW YORK, June 24, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
… | June 24, 2021
INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
/PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Nicolet Bankshares, Inc. (NASDAQ:…
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
BEND, Ore., June 23, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Jaguar Health (NASDAQ:JAGX) shares moved upwards by 18.53% to $2.11 during Monday’s after-market session. This security traded at a volume of …